DEF: Quantum Cyber N.V. 2026 Annual Meeting Proxy Statement

Quantum Cyber N.V. has issued a proxy statement for its June 29, 2026, annual general meeting to vote on board appointments, remuneration policy amendments, and a strategic pivot into quantum-ready autonomous defense platforms.

Summary

• The company will hold its annual general meeting on June 29, 2026, in Amsterdam, Netherlands.
• Shareholders will vote on 11 proposals, including the ratification of Kreston Lentink Audit B.V. as the auditor for 2026.
• The company is seeking approval to expand its corporate objects to include quantum-ready autonomous defense platforms, such as drone warfare and counter-unmanned aircraft systems.
• The board is requesting extensions for authorizations to issue shares, exclude pre-emption rights, and acquire ordinary and preferred shares through December 2027 or June 2031.
• Peter O'Rourke is nominated for appointment as a non-executive director.
• The company proposes significant amendments to its remuneration policy, including increasing annual fixed remuneration for non-executive directors to $100,000 and raising the annual share grant limit for the board to 10,000,000 shares.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral-to-speculative filing; while the strategic pivot offers potential growth, the significant management turnover, reliance on a single investor for capital, and potential for massive share dilution create substantial uncertainty.

Positives

• The company is actively pursuing a strategic pivot into high-growth sectors including post-quantum cryptography, zero-trust architecture, and autonomous defense technologies.
• The board has secured a $6 million investment from CEO David Lazar, signaling internal commitment to the company's new strategic direction.
• The company has established a clear governance structure with a majority of independent directors.

Negatives

• The company reported losses for the fiscal year ended December 31, 2025.
• Significant dilution potential exists due to the conversion of Series A through E Preferred Shares held by the CEO into up to 477,000,000 Ordinary Shares.
• The company is undergoing a major management and board overhaul, with multiple resignations occurring in April 2026.
• The proposed remuneration policy amendments significantly increase potential equity-based compensation for directors.

Risks

• The company's new strategic focus on defense and quantum technology is subject to significant execution and regulatory risks.
• The company is dependent on the successful conversion of preferred shares and the approval of proposals to finalize the investment.
• The company faces potential conflicts of interest given the significant ownership and control held by the CEO, David Lazar.
• The company's ability to operate in the defense sector may be subject to stringent national security regulations and export controls.

Future Outlook

The company intends to expand its activities to include a diversified platform at the intersection of quantum computing and next-generation cybersecurity, while continuing its molecular genetic diagnostics business. It plans to pursue strategic acquisitions and partnerships in post-quantum cryptography, zero-trust architecture, and autonomous defense technologies.

Management Comments

• The Board has determined that each proposal listed is in the best interests of the Company and its shareholders.
• The Board believes that good corporate governance is a critical factor in achieving business success.
• The Board believes that Mr. O'Rourke is well-qualified to serve as a director based on his leadership and consulting experience.

Industry Context

StockSavvy.ai notes that the company is attempting a dramatic pivot from clinical diagnostics to the defense and quantum technology sector, a trend increasingly seen in small-cap firms seeking to leverage current geopolitical and technological tailwinds to attract investor interest.

Comparison to Industry Standards

• The company's shift into defense and quantum technology aligns with broader industry trends of dual-use technology development.
• The proposed remuneration increases for non-executive directors to $100,000 are consistent with competitive compensation packages for small-cap public companies.
• The use of a proxy solicitor (Broadridge) is standard practice for public companies to ensure quorum.

Management Changes

Corporate Governance

Legal Proceedings

• None disclosed.

Related Party Transactions

• Issuance of Series A-E Preferred Shares to CEO David Lazar for $6 million.
• Settlement agreements with executive officers and directors involving payments totaling approximately $1.8 million.

Stakeholder Impact

• Shareholders face significant dilution if the preferred shares are converted.
• The strategic pivot may change the company's risk profile for investors.
• Employees and creditors may be impacted by the change in corporate focus and management.

Next Steps

• Hold the Annual General Meeting on June 29, 2026.
• Tabulate votes and announce results via Form 8-K within four business days.
• Execute the Deed of Amendment to the Articles of Association if approved.
• Finalize the investment from David Lazar upon approval of the proposals.

Key Dates

Recommendation

The company is in a state of significant transition with a major strategic pivot and management overhaul. Investors should wait for clarity on the execution of the new business plan and the impact of the massive potential share dilution before increasing positions.

Keywords

Quantum Cyber, Proxy Statement, Quantum Computing, Cybersecurity, Autonomous Defense, Corporate Governance, Shareholder Meeting, Remuneration Policy